FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2952593374> ?p ?o ?g. }

• W2952593374 endingPage "218" @default.
• W2952593374 startingPage "214" @default.
• W2952593374 abstract "Objective Long-acting reversible contraceptive (LARC) method uptake has been low within the context of HIV prevention trials. Within a multinational study (MTN-020/ASPIRE), the Contraceptive Action Team improved LARC accessibility and uptake. In this secondary analysis, we determined the rate of contraceptive method continuation among the women enrolled. Study design ASPIRE was a randomized, double-blinded, placebo-controlled phase III safety and effectiveness study of the Dapivirine Vaginal Ring for HIV-1 prevention. Between 2012 and 2014, sexually active women aged 18–45 from Malawi, South Africa, Uganda and Zimbabwe were enrolled. All participants were required to use contraception for enrollment to the study and could choose between all highly effective contraceptive methods available in their respective countries. Women were seen monthly and could change methods at any time. Continuation rates from study enrollment to 6 and 12 months were determined. Results The overall contraceptive method continuation rate was 77% (1972/2551) at 6 months and 66% (1694/2551) at 12 months. The 6- and 12-month continuation rates were highest for implantable contraceptives (89%, 82%) followed by copper intrauterine device (83%, 77%). Rates of continuation for injectable contraceptives depot medroxyprogesterone acetate (80%, 69%) and norethisterone enanthate (71%, 54%) were higher than for oral contraceptives, which were continued at 47% at 6 months and 35% at 12 months. The continuation rates of all methods did not differ by users with and without previous contraceptive experience. Conclusions LARC methods have the highest rates of continuation at 12 months and should be routinely offered in the context of HIV prevention trials in sub-Saharan Africa. Implications Intrauterine devices and contraceptive implant continuation was high at 12 months among women participating in an HIV prevention trial in sub-Saharan Africa and LARCs and should be routinely offered." @default.
• W2952593374 created "2019-06-27" @default.
• W2952593374 creator A5007070381 @default.
• W2952593374 creator A5017547539 @default.
• W2952593374 creator A5017590595 @default.
• W2952593374 creator A5028238434 @default.
• W2952593374 creator A5033049388 @default.
• W2952593374 creator A5034611655 @default.
• W2952593374 creator A5038864908 @default.
• W2952593374 creator A5038944401 @default.
• W2952593374 creator A5042179334 @default.
• W2952593374 creator A5046949089 @default.
• W2952593374 creator A5055196212 @default.
• W2952593374 creator A5055769408 @default.
• W2952593374 creator A5078524229 @default.
• W2952593374 date "2019-09-01" @default.
• W2952593374 modified "2023-10-15" @default.
• W2952593374 title "Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study" @default.
• W2952593374 cites W1577202629 @default.
• W2952593374 cites W1971662534 @default.
• W2952593374 cites W1989685346 @default.
• W2952593374 cites W1993072772 @default.
• W2952593374 cites W2022479176 @default.
• W2952593374 cites W2025396127 @default.
• W2952593374 cites W2044369525 @default.
• W2952593374 cites W2095099668 @default.
• W2952593374 cites W2146634980 @default.
• W2952593374 cites W2544080039 @default.
• W2952593374 cites W2589618577 @default.
• W2952593374 cites W2624507456 @default.
• W2952593374 cites W2796020960 @default.
• W2952593374 doi "https://doi.org/10.1016/j.contraception.2019.06.006" @default.
• W2952593374 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6699890" @default.
• W2952593374 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31226323" @default.
• W2952593374 hasPublicationYear "2019" @default.
• W2952593374 type Work @default.
• W2952593374 sameAs 2952593374 @default.
• W2952593374 citedByCount "7" @default.
• W2952593374 countsByYear W29525933742020 @default.
• W2952593374 countsByYear W29525933742021 @default.
• W2952593374 countsByYear W29525933742022 @default.
• W2952593374 countsByYear W29525933742023 @default.
• W2952593374 crossrefType "journal-article" @default.
• W2952593374 hasAuthorship W2952593374A5007070381 @default.
• W2952593374 hasAuthorship W2952593374A5017547539 @default.
• W2952593374 hasAuthorship W2952593374A5017590595 @default.
• W2952593374 hasAuthorship W2952593374A5028238434 @default.
• W2952593374 hasAuthorship W2952593374A5033049388 @default.
• W2952593374 hasAuthorship W2952593374A5034611655 @default.
• W2952593374 hasAuthorship W2952593374A5038864908 @default.
• W2952593374 hasAuthorship W2952593374A5038944401 @default.
• W2952593374 hasAuthorship W2952593374A5042179334 @default.
• W2952593374 hasAuthorship W2952593374A5046949089 @default.
• W2952593374 hasAuthorship W2952593374A5055196212 @default.
• W2952593374 hasAuthorship W2952593374A5055769408 @default.
• W2952593374 hasAuthorship W2952593374A5078524229 @default.
• W2952593374 hasBestOaLocation W29525933742 @default.
• W2952593374 hasConcept C126322002 @default.
• W2952593374 hasConcept C131872663 @default.
• W2952593374 hasConcept C144024400 @default.
• W2952593374 hasConcept C149923435 @default.
• W2952593374 hasConcept C151730666 @default.
• W2952593374 hasConcept C160050368 @default.
• W2952593374 hasConcept C2776306185 @default.
• W2952593374 hasConcept C2779076696 @default.
• W2952593374 hasConcept C2779343474 @default.
• W2952593374 hasConcept C2779755712 @default.
• W2952593374 hasConcept C2781039349 @default.
• W2952593374 hasConcept C2781185258 @default.
• W2952593374 hasConcept C2908647359 @default.
• W2952593374 hasConcept C29456083 @default.
• W2952593374 hasConcept C2986740045 @default.
• W2952593374 hasConcept C2986817661 @default.
• W2952593374 hasConcept C71315377 @default.
• W2952593374 hasConcept C71924100 @default.
• W2952593374 hasConcept C72563966 @default.
• W2952593374 hasConcept C86803240 @default.
• W2952593374 hasConcept C99454951 @default.
• W2952593374 hasConceptScore W2952593374C126322002 @default.
• W2952593374 hasConceptScore W2952593374C131872663 @default.
• W2952593374 hasConceptScore W2952593374C144024400 @default.
• W2952593374 hasConceptScore W2952593374C149923435 @default.
• W2952593374 hasConceptScore W2952593374C151730666 @default.
• W2952593374 hasConceptScore W2952593374C160050368 @default.
• W2952593374 hasConceptScore W2952593374C2776306185 @default.
• W2952593374 hasConceptScore W2952593374C2779076696 @default.
• W2952593374 hasConceptScore W2952593374C2779343474 @default.
• W2952593374 hasConceptScore W2952593374C2779755712 @default.
• W2952593374 hasConceptScore W2952593374C2781039349 @default.
• W2952593374 hasConceptScore W2952593374C2781185258 @default.
• W2952593374 hasConceptScore W2952593374C2908647359 @default.
• W2952593374 hasConceptScore W2952593374C29456083 @default.
• W2952593374 hasConceptScore W2952593374C2986740045 @default.
• W2952593374 hasConceptScore W2952593374C2986817661 @default.
• W2952593374 hasConceptScore W2952593374C71315377 @default.
• W2952593374 hasConceptScore W2952593374C71924100 @default.
• W2952593374 hasConceptScore W2952593374C72563966 @default.
• W2952593374 hasConceptScore W2952593374C86803240 @default.

• next